Mimedx (MDXG) Amortization - Intangibles (2012 - 2026)
Mimedx's (MDXG) quarterly Amortization - Intangibles came in at $301000.0 in Q1 2026, up 204.04% year-on-year from $99000.0 in Q1 2025, and up 133.33% quarter-over-quarter from $129000.0 in Q4 2025.
Mimedx (MDXG) Amortization - Intangibles (2012 - 2026) Analysis & Trends
Mimedx has disclosed Amortization - Intangibles across 15 years of filings, most recently posting $301000.0 for Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $301000.0, up 204.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $642000.0 (down 4.75% YoY), and the FY2025 annual result was $439000.0, down 42.61% from the prior year.
- Amortization - Intangibles came in at $301000.0 for Q1 2026 at Mimedx, up from $129000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $301000.0 in Q1 2026 to a low of $99000.0 in Q1 2025.
- The 5-year median for Amortization - Intangibles is $189000.0 (2024), against an average of $174705.9.
- Across the five-year window, Amortization - Intangibles tumbled 47.62% in 2025 and jumped 204.04% in 2026, its largest moves.
- Mimedx's Amortization - Intangibles stood at $182000.0 in 2022, then gained by 5.49% to $192000.0 in 2023, then increased by 0.52% to $193000.0 in 2024, then sank by 33.16% to $129000.0 in 2025, then jumped by 133.33% to $301000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $301000.0 (Q1 2026), $129000.0 (Q4 2025), and $112000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 190,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 173,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 215,000.00 |